Clinical trial
Gabapentin for Abstinence Initiation in Alcohol Dependence
NCT01141049 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Gabapentin for Abstinence Initiation in Alcohol Dependence
- Lead sponsor
- New York State Psychiatric Institute
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- August 31, 2010
- Completion date
- December 31, 2012
- Enrollment
- 40 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
alcohol dependence